524717 — Titan Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹10.45bn
- IN₹10.42bn
- IN₹1.56bn
Annual cashflow statement for Titan Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 427 | 290 | 281 | 315 | 244 |
| Depreciation | |||||
| Non-Cash Items | 19.4 | 11.5 | 10.9 | 14.3 | 11.2 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -278 | -104 | -106 | -151 | -95.4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 191 | 220 | 212 | 211 | 201 |
| Capital Expenditures | -48.6 | -137 | -132 | -197 | -94.4 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | -27.6 | -75.5 | -6.14 | -4.31 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -48.6 | -164 | -207 | -203 | -98.7 |
| Financing Cash Flow Items | -16.7 | -8.72 | -7.46 | -11.7 | -8.02 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -106 | -41 | -24 | -28.7 | -79.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 36.2 | 15.1 | -19.5 | -20.2 | 22.9 |